| Abstrakt: |
Recent improvements in the treatment of childhood acute lymphatic leukaemia and nephroblastoma, together with evidence from animal experiments, have raised the possibility that occult spread from adult solid tumours may be sterilized by “adjuvant” treatment. The search for suitable tumour markers has also been given new impetus, to help identify the patients most likely to have recurrent or metastatic disease. Tumour markers and adjuvant therapy were thus an excellent choice for the 1978 Paris meeting of the EORTC and the proceedings have now been published in volumes 67 and 68 of Recent Results in Cancer Research. |
